A differential immunoturbidimetric procedure for the quantitation of apolipoprotein A-I associated with lipoproteins LpA (containing both apolipoprotein A-I and apolipoprotein A-II) and with lipoproteins LpA-I (containing apolipoprotein A-I but no apolipoprotein A-II) is presented. Lipoproteins containing apolipoprotein A-II are precipitated with an anti-apolipoprotein A-II antibody. The resulting immunoprecipitate is sedimented and LpA-I A _i is measured in the supernate. Whereas LpA-I A _! concentrations differed significantly between normolipidaemic men and women (0.75 and \ .00 g/1, respectively), there was virtually no sex related difference in LpA A _i (0.83 and 0.88 g/1, respectively). LpA-I A .i was predominantly correlated with HDL 2 -cholesterol (r s = 0.630), whereas LpA A . r was statistically associated with HDL 3 (r s = 0.417).
Introduction
Plasma HDL 1 ) are involved in cholesterol esterification and transport. Clinical and epidemiological data suggest an inverse relationship between HDL concentration and cardiovascular risk (1) . HDL do not consist of an homogeneous molecular species, but represent a complex mixture of lipoprotein particles differing in physicpchemical characteristics such as hydrated density, particle size, lipid and apolipoprotein composition (2) .
Apolipoprotein A4 and apolipoprotein A-II are the major HDL apolippproteins. Together they constitute approximately 90% of the protein associated with HDL. In normolipidaemic human plasma more than ! ) Abbreviations: VLDL, LDL, HDL: very low, low, and high density lipoproteins; LpA, lipoproteins with apolipoprotein A-I and apolipoprotein A-II; LpA-I, lipoproteins with apolipoprotera A-I but no apolipoprotein A-II; LpA A . b LpA*I A -i, apolipoprotein A-I associated with LpA and LpA-I, respectively; EDTA, ethylenediaminetetraacetate; TRIS, tris(hydroxymethyl)aminomethane; ELISA, enzyme-linked immunosorbent assay.
90% of apolipoprotein A-I and 95% of apolipoprotein A-II are found within the HDL density range. Both apolipoproteins modulate lecithin cholesterol acyltransferase (EC 2.3.1.43) activity (3) and appear to be ligands for HDL receptors (4) . Apolipoprotein A-II is an activator of hepatic triacylglycerol lipase (EC 3.1.1.34) (5) .
At least two forms of apolipoprotein A containing lipoproteins can be distinguished: particles with both apolipoprotein A-I and apolipoprotein A-II (= LpA), and particles with apolipoprotein A-I but no apolipoprotein A-II (= LpA-I) (6 -9) . Recent observations suggest that LpA-I, but not LpA, promote cholesterol efflux from cultured adipose cells (10) .
Differential quantitation of the two particle species has been accomplished by 'tandem gel' electroimmunoassay (11, 12) , differential antibody ELISA (13) and radioimmunoassay following immunoprecipitation (14) . Herein we report the development of a simple immunoturbidimetric procedure for the quantification of the two particle species in terms of their apolipoprotein A-I moiety (LpA A .i and LpA-I A -i).
Materials and Methods
Plasma samples Blood samples were obtained from healthy donors after an overnight fast and drawn into tubes containing EDTA · K 2 (final concentration 1.5-2 g/1). Plasma was recovered by low speed centrifugation (1500g, 30 min).
Preparation of LpA-I HDL were isolated from pooled human serum (supplemented with 0.4 g/1 EDTA · Na 2 and 0.5 g/1 NaN 3 ) by sequential preparative ultracentrifugation in a KONTRON type TFT 50.38 rotor within the density range of 1.063 kg/1 (44000 min-1 , 2.6 · 10 s £ · min) and 1.21 kg/1 (44000 min-1 , 3.4 · 10 8 g · min). Densities were adjusted with solid NaBr and monitored with a DMA 55 digital precision density meter (A. Paar, Graz, Austria). HDL were washed by recentrifugation at d = 1.21 kg/1 and then subfractionated by chromatofocusing as described by Nestruck et al. (15) . In brief, HDL (25 -35 mg protein) were dialysed against the chromatofocusing starting buffer (piperazine-HCl, pH 5.8), applied to a column (bed height 38 cm, diameter 1 cm) with Polybuffer Exchanger (Pharmacia Fine Chemicals, Uppsala, Sweden) and eluted with Polybuffer 74 (diluted 1:15 with bidistilled water, pH 4.0) at a flow rate of 22 ml/h. Additional chromatofocusing experiments were carried out with 250 ml/1 glycerol present in all solutions.
'Tandem gel' electroimmunoassay for LpA-I A _j An electroimmunoassay plate was subdivided into anti-apolipoprotein A-II and anti-apolipoprotein A-I containing sections. During sample migration, lipoproteins containing apolipoprotein A-II were retained in the anti-apolipoprotein A-II containing section, whereas LpA-I reached the attached gel with antiapolipoprotein A-I (11, 12).
Our electrophoresis buffer contained 25 mmol/1 barbital, 70 mmol/1 TRIS-HC1, pH 8.8, 107 mg calcium lactate, and 130 mg/1 NaN 3 . The gel consisted of 10 g/1 agarose (Seakem LE, -mr = 0.10-0.15), and 20 g/l dextran T70 (Pharmacia). Rabbit anti-apolipoprotein A-II (35 ml/l) (Immuno AG, Vienna, Austria) or rabbit anti-apolipoprotein A-I (40 ml/1) (Immuno) were added to the gel solution. The sample volume was 5 μΐ. Electrophoresis was performed at a constant current of 20 mA and 15 °C for 5 h. Staining with Coomassie Brilliant Blue was performed as described (16) , and rocket lengths were determined in tenths of a millimeter with a viewer for immunoanalysis (Behringwerke, Marburg, FRG).
Non-competitive ELISA for apolipoprotein A-II Microtitre plates (Nunc Immuno Plate I) were coated overnight with 0.1 ml anti-apolipoprotein Α-ΙΙ-γ-globulin (from sheep, Boehringer Mannheim) diluted 1:500 (corresponding to a final concentration of around 7 mg/1 specific anti-apolipoprotein A-II) in 0.2 mol/1 carbonate buffer, pH 10.0, blocked in 10 g/1 gelatine (in coating buffer), and washed with 0.2 ml phosphate buffered saline containing 0.5 ml/1 Tween 20. Samples (0.1 ml) were incubated for 4 h and the solid phase was subsequently blocked, washed twice, and incubated l h with 0.1 ml 1:500 diluted anti-apolipoprotein A-II (from rabbit, Immuno). After three additional washes the wells were incubated for l h with 0:1 ml 1:500 diluted horseradish peroxidase conjugated to antirabbit-IgG (from goat, Biorad Laboratories, Munich, FRG). Colour was developed with an -phenylene diamine (OPD) reagent (Abott Diagnostic Products, Wiesbaden, FRG). The reaction was stopped by addition of 0.5 mol/1 H 2 SO 4 and absorbances were read at 450 nm (titertek MCC 340, Flow Laboratories).
Differential turbidimetric measurement of LpA A . f and LpA-I A -i Lipoproteins containing apolipoprotein Α-ΙΪ were immunoprecipitated with an antibody specific for apolipoprotein Α-ΪΙ. Subsequently, immune complexes were sedimented by centrifugation and LpA-I A _i was determined, in an aliquot of the supernate.
In detail: Plasma was diluted 20-fold with 10 minol/1 potassium phosphate, pH 7.4, 0.15 mol/1 NaCl. Sheep polyclonal antiapolipoprotein A^II (γ-globulin fraction, 3.5 g specific antibody per litre, Boehringer Mannheim) was diluted tenfold with the same buffer additionally containing 40 g/l polyethylene glycol (M r 6000, Serva Heidelberg, FRG). In addition, 10-, 15-, 20-, 30-, and 40-fold dilutions of the secondary standard serum, sample blanks (1.0 ml phosphate/NaCl with polyethylene glycol plus 50 μΐ of the diluted sample) and a reagent blank were prepared. Diluted sample or standard (50 μΐ) was mixed with 1 ml of the diluted antibodies. After incubation for 2 1 A h at 20-25 °C, the mixture was swirled and absorbances read at 365 nm: sample against reagent blank and sample blank against phosphate buffer with polyethylene glycol. This step provided a value for the total apolipoprotein Α-ΙΪ concentration. The immunoprecipitate was then sedimented by centrifugation at 2000 g for 20 min, and 0.9 ml of the supernate was transferred to fresh tubes (It has been confirmed by absorbance measurements of the supernate that the immunoprecipitate is completely removed under these conditions). 0.1 ml undiluted polyclonal anti-apolipoprotein A-I (γ-globulin fraction from sheep, 5.2 g specific antibody per litre, Boehringer Mannheim) was added, incubated for 2 1 A h, and the absorbance measurements were repeated. Finally, LpA-I A .i was determined by reference to the calibration curve, and LpA A _i was calculated as the difference between total apolipoprotein A-I (measured with the sheep antiapolipoprotein A-I from Boehringer Mannheim according to the supplier's instructions) and LpA-I A . r .
Standardization
Two approaches were pursued to quantify LpA A _! and LpA-I A _i in a deep-frozen reference pool of human plasma, which then served as a secondary calibrator for the differential turbidimetric assay: a) LpA-I isolated by chromatofocusing was used as a standard in a 'tandem gel' electroimmunoassay for LpA-I A .|. Apolipoprotein A-I had been measured in this preparation by zone immunoelectrophoresis (16, 17) in reference to a lyophilized commercial standard serum (Reference Standard for human apolipoproteins, Immuno AG, apolipoprotein A-I: 0.825 g/1).
b) LpA-I was measured in terms of its apolipopfotein A-I content in the supernate after precipitation of LpA with anti-apolipoprotein A-II. Here again a commercial reference serum (Apolipoprotein Standard Boehringer Mannheim, apolipoprotein A-I: 1.45 g/1) served as the standard.
Miscellaneous analytical methods
Zone immunoelectrophoresis (16, 17) and discontinuous polyacrylamide gel electrophoresis (T = 12.5%, C = 2.7%) in the presence of SDS (18) were performed as described. Cholesterol, triacylglycerols and phospholipids were measured enzymatically using commercial reagents (Boehringer Mannheim). VLDLcholesterol and HDL-cholesterol were determined with a combined centrifugation/precipitation method (19) . HDL 2 and HDL 3 were separated by ultracentrifugation at d = 1.125 kg/1 in the supernate after precipitation (phosphotungstate/MgCl 2 ) of apolipoprotein B-containing lipoproteins (20) .
Statistics
The statistical analysis (rank sum test of Mann, Whitney, and Wilcoxon, Spearman's rank correlation) was carried out with the SPSS X batch system (release 2.0 on Sperry 1100). fig. 3 ). This indicates that apolipoprotein A-II containing lipoproteins are virtually completely removed by the immunoprecipitation step throughout the concentration range covered by the turbidimetric assay.
Results

Preparation of
Calibration curves for the estimation of LpA-I A -i, total apolipoprotein A-I and apolipoprotein A-II constructed from dilutions of the reference serum are shown in figure 4 . Within a broad measuring range there are linear responses to the amounts of either antigen. The standard curves for apolipoprotein A-I in either LpA-I or whole plasma coincide, suggesting that the immiinoreaction is insensitive to the nature of the apolipoprotein A-I containing particle. In normolipidaemic samples, reagent blanks were always within 0.02 absorbance units. Some hypertriglyceridaerriic sera, however, gave higher values, ranging from 0.03 to 0.06. In order to exclude the possibility that net absorbance readings were substantially influenced by triacylglycerol-rich lipoproteins, we enriched a normolipidaemic plasma with highly concentrated VLDL prepared from a plasma pool of normolipidaemic donors. Within the range of 1.14 mmol/1 to 3.2 mmol/1 triacylglycerols absorbances remained unaffected although the sample blanks increased from 0.006 to 0.022.
The within batch coefficient of variation was 4.4% (n = 10) for the determination of LpA-I/^. Its between batch coefficient of variation was 8.6% as estimated by analyses of a deep frozen (-25°C) plasma sample (mean LpA-I A _! = 0.62 g/1) on η = 8 working days. 
Discussion
The turbidimetric procedure for the differential determination of LpA-I A -i and LpA A -i is rapid and simple. As has been verified by an ELISA technique and zone immunoelectrophoresis, the immunoprecipitation with anti-apolipoprotein A-II affords complete removal of apolipoprotein A-II containing particles. Thus the subsequent assay for LpA-I^j is specific. Two strategies for its standardization arrived at virtually identical results. This suggests that the procedure has been calibrated accurately, and that, in routine practice, the turbidimetric determination of apolipoprotein A-I in the supernate after precipitation of LpA will permit convenient yet accurate standardization. Hence, the differential method is readily available to any laboratory already running turbidimetric determinations of apolipoprotein A-I and apolipoprotein A-II.
Although in general the incorporation of detergents into turbidimetric assays eliminates background turbidity, they were omitted here in order to preserve the original lipoprotein structure. A sample blank should therefore be run in parallel in particular for hypertriglyceridaemic sera.
Hitherto, differential quantitation of LpA and LpA-I have been carried out by 'tandem gel' (i. e. double gel) electroimmunoassay (11, 12) , ELISA (13) or by radioimmunoassay after precipitation of LpA (14) . This is the first report on a turbidimetric assay for the two particle species. Compared with the other techniques it has several advantages: it is less tedious, does not demand specific equipment and may partially be automated. Drawbacks are antibody consumption and comparatively lower sensitivity which, however, is perfectly adequate for determination of plasma concentrations encountered in practice, and the method incidentally avoids large-scale dilution as a source of analytical error.
Differential measurement of LpA and LpA-I allows the straightforward classification of variations in the plasma apolipoprotein A-I/A-II ratio which, in principle, may be brought about by either changes in the composition of the apolipoprotein -containing lipoproteins or by variations in the relative proportions of their subspecies.
Our reference values for LpA-I and LpA were established in a limited population sample and may therefore be considered as preliminary. Nevertheless, they are in fair accordance with data obtained with 'tandem gel' electroimmunoassay (11) and differential antibody ELISA (13) , and, in keeping with the latter study, they suggest that the well documented sex difference in apolipoprotein A-I is attributable to LpA-I rather than to LpA.
The present work also provided statistical evidence that LpA-I is associated to some extent with HDL 2 , which is concurrently regarded the major anti-atherogenic HDL-subfraction. This may be related to the observation that within HDL 2 roughly two thirds of apolipoprotein A-I reside on the LpA-I subspecies (13).
In conclusion, our method provides an efficient tool for the quantitative differentiation of LpA and LpA-J. Further clinical and experimental research is now required to gain insights into the physiological and diagnostic significance of the two particle subpopulations.
